华森制药股东刘小英拟减持不超3%公司股份

Group 1 - The core point of the article is that Liu Xiaoying plans to reduce her shareholding in Huasen Pharmaceutical (002907) by a total of up to 12.52 million shares, which represents a maximum of 3% of the company's total share capital [2][3] Group 2 - Liu Xiaoying currently holds 35.8947 million shares of the company [2] - The planned reduction includes a maximum of 4.176 million shares through centralized bidding, not exceeding 1% of the total share capital [2] - Additionally, up to 8.3519 million shares may be sold through block trading, not exceeding 2% of the total share capital [2]